Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the Dongfeng–Tongji cohort study

Serum alpha‐fetoprotein (AFP) is the most commonly used tumor biomarker for screening and diagnosis of primary hepatocellular carcinoma (HCC). However, the predictive effect for HCC risk is still unsatisfactory. The aim of this prospective study was to estimate whether the individual genetic correct...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Wang, Ke, Bai, Yansen, Chen, Shi, Huang, Jiao, Yuan, Jing, Chen, Weihong, Yao, Ping, Miao, Xiaoping, Wang, Youjie, Liang, Yuan, Zhang, Xiaomin, He, Meian, Yang, Handong, Guo, Huan, Wei, Sheng
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Cancer Prevention
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6010894/
https://ncbi.nlm.nih.gov/pubmed/29696820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1481
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados